Journal of Nanobiotechnology (Oct 2024)

Neutrophil N1 polarization induced by cardiomyocyte-derived extracellular vesicle miR-9-5p aggravates myocardial ischemia/reperfusion injury

  • Yeshen Zhang,
  • Xinzhong Li,
  • Yining Dai,
  • Yuan Han,
  • Xiaomin Wei,
  • Guoquan Wei,
  • Weikun Chen,
  • Siyu Kong,
  • Yu He,
  • Haobin Liu,
  • Ning Ma,
  • Jianping Bin,
  • Ning Tan,
  • Pengcheng He,
  • Yuanhui Liu

DOI
https://doi.org/10.1186/s12951-024-02902-w
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 25

Abstract

Read online

Abstract Neutrophil polarization contributes to inflammation and its resolution, but the role of neutrophil polarization in myocardial ischemia/reperfusion (I/R) injury remains unknown. Cardiomyocytes (CMs) participate in cardiac inflammation by secreting extracellular vesicles (EVs). Therefore, we investigated the role of neutrophil polarization in myocardial I/R injury and the mechanism by which CM-derived EVs regulated neutrophil polarization. In the present study, our data showed that N1 neutrophil polarization enlarged cardiac infarct size and exacerbated cardiac dysfunction at the early stage of myocardial I/R. Further, CM-EV-derived miR-9-5p was identified as a mediator inducing neutrophils to the N1 phenotype. Mechanistically, miR-9-5p directly suppressed SOCS5 and SIRT1 expression, resulting in activating JAK2/STAT3 and NF-κB signaling pathways in neutrophils. Importantly, we confirmed that serum EV-derived miR-9-5p levels were independently associated with cardiovascular mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. These findings suggest neutrophil polarization is a promising therapeutic target against myocardial I/R-induced inflammation and injury, and serum EV-derived miR-9-5p is a promising prognostic biomarker for cardiovascular mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Graphical Abstract

Keywords